LC
SNY icon

Lourd Capital’s Sanofi SNY Stock Holding History

Lourd Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9,779
Closed -$425K – 267
2018
Q4 		$425K Buy
9,779
+864
+10% +$38.1K 0.03% 137
2018
Q3 		$398K Buy
+8,915
New +$381K 0.03% 162
2018
Q1 		– Sell
-11,079
Closed -$476K – 300
2017
Q4 		$476K Buy
+11,079
New +$511K 0.03% 162

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lourd Capital's SNY Position: Q1 2019 in Review

Lourd Capital sold out of Sanofi (SNY) in Q1 2019, closing a stake of 9,779 shares — an estimated $425K sold.

Lourd Capital first reported a position in SNY in Q4 2017 and held it in 3 quarters. The position peaked at $476K in Q4 2017. 489 funds tracked by Wall St. Rank hold SNY as of Q1 2019.

  • Lourd Capital reported no remaining Sanofi position as of Q1 2019 after selling out during the quarter.
  • Lourd Capital sold 9,779 Sanofi shares in Q1 2019, an estimated $425K.
  • Lourd Capital first reported a position in Sanofi in Q4 2017 and held it in 3 quarters.
  • Lourd Capital's Sanofi position peaked at $476K in Q4 2017.
  • 489 funds tracked by Wall St. Rank held Sanofi as of Q1 2019.

Based on Lourd Capital's 13F filing for Q1 2019, filed 16 Apr 2019.